imatinib mesylate has been researched along with Infective Endocarditis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hutyra, M; Kozák, J; Lukl, J; Szotkowski, T; Táborský, M; Václavík, J | 1 |
1 other study(ies) available for imatinib mesylate and Infective Endocarditis
Article | Year |
---|---|
Development of Löffler's endocarditis in FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome despite continuous imatinib mesylate therapy and continuous complete remission.
Topics: Adrenal Cortex Hormones; Adult; Anticoagulants; Benzamides; Drug Therapy, Combination; Endocarditis; Eosinophils; Heart; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Male; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Prednisone; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Remission Induction; Thrombosis; Treatment Outcome; Warfarin | 2010 |